In the context of NASH, systematic SIRT1 ablation or hepatocyte SIRT1 deletion led to hepatic steatosis and inflammation [54,55], and SIRT1 overexpression protected against diet-induced steatosis [56,57]. Here, SIRT1 is linked to metabolic dysfunction-associated steatohepatitis.